S 03 - Technologically Driven strategies in HPVrelated OPSCC
Niema Razavian, MD (Session Moderator)
3 - 4 p.m.
Room 162

115 - International Pilot of an Immersive Virtual-Reality-Based Training in Intracavitary Cervical Cancer Brachytherapy Treatment: Educational Impact and Early Outcomes
John Peterson
3 - 3:30 p.m.
Room 253

119 - Assessing Burnout and Retention Risk Among Radiation Therapists During Departmental Expansion
Samantha Webking
3:40 - 3:50 p.m.
Room 109

2011 - The Presentation of Leptomeningeal Disease by Breast Cancer Subtype and Potential Implications for Surveillance Brain MRIs
Jennifer Barranco
3 - 4 p.m.
Poster Hall

2124 - Impact of the Integrated Pathologic Score on Clinical Outcomes in Resected Esophageal Cancer following Neoadjuvant Chemoradiation
Jin Ju Lee
3 - 4 p.m.
Poster Hall

2324 - Perceptions and Attitudes of Multidisciplinary Oncology Physicians and Advanced Practice Providers (APPs) Regarding Stereotactic Body Radiotherapy (SBRT) for Gastrointestinal (GI) Cancers
Sarah Goodchild
4 - 5 p.m.
Poster Hall

210 - Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Kamran Ahmed, MD
3 - 3:10 p.m.
Room 204

EDU 28 - Redefining Care for Thoracic Neuroendocrine Tumors: A Multidisciplinary Update
Jongmyung Kim, PhD (Session Moderator)
3 - 4 p.m.
Room 157

2539 - Prognostic Impact of Comprehensive Genomic Profiling Stratified by STK11 Status in NSCLC Treated with the PACIFIC Regimen
Levi Martinka
10:45 a.m.- 12 p.m.
Poster Hall

2430 - Validation of a Population-Based GARD Tumor Control Model Using Published Carbon Ion Dose Escalation Outcomes in Stage I NSCLC
Celina Chiodo
10:45 a.m.- 12 p.m.
Poster Hall

2566 - Genomics-Based Brain Metastasis Risk Model in Stage II-III NSCLC after Concurrent Chemoradiotherapy and Consolidative Immunotherapy
Kolade Olabode
10:45 a.m.- 12 p.m.
Poster Hall

2466 - iRAI-DiT - A Dose Informed Transformer with Early Cross Attention Fusion for Radiotherapy Dose Prediction from in vivo Ionizing Radiation Acoustic Signals
Glebus Gonzalez
10:45 a.m.- 12 p.m.
Poster Hall

2714 - Clinical Outcomes of De Novo Oligometastatic Breast Cancer Patients Treated with Curative Intent
Celina Chiodo
3 - 4 p.m.
Poster Hall

2838 - Preserving Function with Induction therapy: High Local Control Rates for Locally Advanced Anal Cancer
Simran Polce
3 - 4 p.m.
Poster Hall

2919 - Long-Term Recurrence Outcomes After HDR Brachytherapy Accelerated Partial Breast Irradiation Stratified by Genomic Risk in Early-Stage Breast Cancer
John Wilson V
3 - 4 p.m.
Poster Hall

2539 - Prognostic Impact of Comprehensive Genomic Profiling Stratified by STK11 Status in NSCLC Treated with the PACIFIC Regimen
Levi Martinka
4 - 5 p.m.
Poster Hall

3096 - Dosimetric Outcomes and Clinical Toxicity from CT-Based Online Adaptive Hypofractionated Radiotherapy for Non-Operable Pancreatic Cancer
John Peterson
4 - 5 p.m.
Poster Hall

Evolving Systemic and Radioligand Strategies in Thoracic Neuroendocrine Tumors: Current Evidence and Future Directions
Jonathan Strosberg, MD
3:32 - 3:47 p.m.
Room 157

1117 - Improving Radiation Oncology Nursing Competence through a Structured, Needs-Based Education Initiative
Kailey Gay
12:45 - 12:50 p.m.
Room 109

EDU 39 - Handling CNS Metastases in Sick Patients
Emily Keit, MD (Session Moderator)
12:30 - 1:45 p.m.
Room 256

261 - Clinical and Genomic Landscape of Recurrence After Concurrent Chemoradiotherapy and Adjuvant Immunotherapy in Unresectable NSCLC
Kolade Olabode
12:40 - 12:50 p.m.
Room 107

SS 35 - SBRT for Pancreaticobiliary Cancer, a SOFT Hand or a Lethal Blo
Jessica Frakes, MD (Session Moderator)
2:15  -3:30 p.m.
Room 254

1146 - Adjuvant Endocrine Therapy Adherence and Outcomes in Early Breast Cancer Patients Treated With APBI: A Retrospective Analysis Stratified by LUMINA Criteria
John Wilson V
5:25 - 5:30 p.m.
Room 253

1186 - Identifying Gaps in Pre-Treatment Patient Education for Radiation Therapy: Insights from Radiation Therapists
Jin Ju Lee
5:45 - 5:50 p.m.
Room 254

3096 - Dosimetric Outcomes and Clinical Toxicity from CT-Based Online Adaptive Hypofractionated Radiotherapy for Non-Operable Pancreatic Cancer
John Peterson
12:30 - 1:45 p.m.
Poster Hall

3397 - Cross-Continental Transcriptomic Evaluation of a Multimodal AI-Based Biomarker in Localized Prostate Cancer
Samantha Webking
2:15 - 3:30 p.m.
Poster Hall

3407 - Circulating Tumor DNA Dynamics in Oligometastatic Urothelial Carcinoma Treated with Stereotactic Body Radiation Therapy
Dekuang Zhao
2:15 - 3:30 p.m.
Poster Hall

3246 - A Single Institution Experience Comparing Outcomes of Muscle Invasive Bladder Cancer of Urothelial or Alternative Histology Treated with Trimodality Therapy
Celina Chiodo
2:15 - 3:30 p.m.
Poster Hall

3577 - Association Between Cardiac Substructure Dose and Survival in NSCLC Patients Treated with Concurrent Chemoradiotherapy
Dipesh Niraula
3:45 - 5 p.m.
Poster Hall

3556 - Real-World Prognostic Impact of PD-L1 Status in Unresectable NSCLC Treated with Concurrent Chemoradiation and Consolidative Immunotherapy
Levi Martinka
3:45 - 5 p.m.
Poster Hall

Challenging Cases of Integrating RT in MM Care
Nicholas Figura, MD
1:12 - 1:32 p.m.
Room 204

Case-Based Reirradiation in Head and Neck Cancer - Indications, Recommendations, and Practical Considerations
Michelle Echevarria, MD (Spanish)
2:20 - 2:30 p.m.
Room 204

Contemporary Radiotherapy Strategies for High-Risk Cutaneous Squamous Cell Carcinoma
Evan Wuthrick, MD
2:37 - 2:57 p.m.
Room 205

1208 - Patient-Centered Visualization in Telehealth: A Digital Innovation to Improve Understanding, Satisfaction and Quality of Care 
Simran Polce
8:20 - 8:25 a.m.
Room 160

QP 35 - Digital Allies: AI Tools Built for the Real Clinical Environment
Sarah Hoffe, MD (Session Moderator)
8 - 9 a.m.
Room 160

Multi-D Care for Rare GU Cancers: The Urologic Surgeon's Perspective
Philippe Spiess, MD
8:32 - 8:47 a.m.
Room 258